BKYI BIO-key International Inc.

BIO-key International Inc.

Computer Software: Prepackaged Software

Technology

BIO-key International, Inc., together with its subsidiaries, develops and markets fingerprint identification biometric technology, enterprise-ready identity access management solutions, and software solutions to commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

IPO Year:

Exchange: NASDAQ

Website: bio-key.com

Recent Analyst Ratings for BIO-key International Inc.

Date	Price Target	Rating	Analyst

See more ratings

BIO-key International Inc. Press Releases

Fastest customizable press release news feed in the world

View All

BIO-key Partners with VaporVM to Expand Reach of its Advanced Identity and Access Management and Biometric Cybersecurity Solutions in Middle East and Africa

DUBAI, United Arab Emirates and HOLMDEL, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a leading provider of Identity and Access Management (IAM) and biometric authentication solutions, has executed a strategic partnership with VaporVM, a global leader in cloud, cybersecurity, and managed services headquartered in Dubai, U.A.E. This collaboration expands the potential for BIO-key to deliver its robust identity, authentication, and access management solutions to enterprises, public sector organizations, and institutions across the Middle East and Africa. The partnership combines VaporVM's cloud-native expertise, regional presence and customer base with

11/12/25 4:00:00 AM ET

BIO-key International Inc.

Recent Analyst Ratings for BIO-key International Inc.

BIO-key International Inc.

Recent Analyst Ratings for BIO-key International Inc.

BIO-key International Inc. Press Releases

BIO-key Partners with VaporVM to Expand Reach of its Advanced Identity and Access Management and Biometric Cybersecurity Solutions in Middle East and Africa

BIO-key Showcases Biometric Identity Innovations at Africa Tech Festival 2025, November 10-13

Digital Identity and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 14th at 10am ET

BIO-key Secures Significant Identity and Biometric Security Deployment with a Major Middle East Defense Sector Organisation

BIO-key International Enters into $3.1 Million Warrant Inducement Transaction

BIO-key International and IT2Trust Partner to Strengthen IAM and Biometric Security Across the Nordic Region of Denmark, Sweden, Norway and Finland

BIO-key Introduces EcoID III USB Fingerprint Scanner Delivering FBI FAP 20 Certification, Security, Liveness Detection, and Encrypted Device-to-Host Communication

BIO-key Showcases Next-Generation Identity & Biometric Authentication Solutions at Premier Tech and Cybersecurity Events: GITEX 2025 in Dubai and 19ENISE in Spain

BIO-key Q2'25 Revenue Rose 49% Driven by Increases Across All Three Segments; Launches "BIO-key CyberDefense Initiative" to Support Growing Global Investment in Military and Defense Preparedness; Investor Call 10am ET Today

BIO-key, Provider of Identity and Access Management Solutions with Enhanced Biometrics, Hosts Q2 Investor Call Wed. Aug. 13th at 10am ET

BIO-key International Inc. Analyst Ratings

Bio-key upgraded by Maxim Group with a new price target

BIO-key International Inc. SEC Filings

BIO-key International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

BIO-key International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

BIO-key International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

SEC Form S-8 filed by BIO-key International Inc.

SEC Form S-8 filed by BIO-key International Inc.

BIO-key International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

SEC Form 10-Q filed by BIO-key International Inc.

BIO-key International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

BIO-key International Inc. filed SEC Form 8-K: Financial Statements and Exhibits

SEC Form DEF 14A filed by BIO-key International Inc.

BIO-key International Inc. Insider Purchases

Amendment: Chief Executive Officer Depasquale Michael W bought $3,233 worth of shares (4,117 units at $0.79), increasing direct ownership by 4% to 102,775 units (SEC Form 4)

Chief Executive Officer Depasquale Michael W bought $3,233 worth of shares (4,117 units at $0.79), increasing direct ownership by 4% to 112,174 units (SEC Form 4)

Chief Legal Officer Sullivan James David bought $7,700 worth of shares (10,000 units at $0.77), increasing direct ownership by 22% to 54,851 units (SEC Form 4)

Chief Executive Officer Depasquale Michael W bought $3,900 worth of shares (5,000 units at $0.78), increasing direct ownership by 10% to 53,519 units (SEC Form 4)

Chief Executive Officer Depasquale Michael W bought $3,320 worth of shares (4,000 units at $0.83), increasing direct ownership by 9% to 48,519 units (SEC Form 4)

Chief Executive Officer Depasquale Michael W bought $4,050 worth of shares (5,000 units at $0.81), increasing direct ownership by 13% to 44,519 units (SEC Form 4)

Depasquale Michael W bought $3,600 worth of shares (20,000 units at $0.18), increasing direct ownership by 7% to 306,827 units (SEC Form 4)

Sullivan James David bought $3,300 worth of shares (20,000 units at $0.17), increasing direct ownership by 5% to 388,171 units (SEC Form 4)

Sullivan James David bought $6,505 worth of shares (39,671 units at $0.16), increasing direct ownership by 12% to 368,171 units (SEC Form 4)

Sullivan James David bought $49,892 worth of shares (285,100 units at $0.17), increasing direct ownership by 175% to 358,500 units (SEC Form 4)

BIO-key International Inc. Insider Trading

Amendment: Chief Executive Officer Depasquale Michael W bought $3,233 worth of shares (4,117 units at $0.79), increasing direct ownership by 4% to 102,775 units (SEC Form 4)

Chief Executive Officer Depasquale Michael W bought $3,233 worth of shares (4,117 units at $0.79), increasing direct ownership by 4% to 112,174 units (SEC Form 4)

Chief Financial Officer Welch Cecilia C was granted 35,000 shares, increasing direct ownership by 143% to 59,396 units (SEC Form 4)

Chief Legal Officer Sullivan James David was granted 40,000 shares, increasing direct ownership by 73% to 94,851 units (SEC Form 4)

Chief Technology Officer Lacous Mira K was granted 25,000 shares, increasing direct ownership by 232% to 35,758 units (SEC Form 4)

Chief Executive Officer Depasquale Michael W was granted 45,000 shares, increasing direct ownership by 84% to 98,658 units (SEC Form 4)

Chief Legal Officer Sullivan James David bought $7,700 worth of shares (10,000 units at $0.77), increasing direct ownership by 22% to 54,851 units (SEC Form 4)

Chief Executive Officer Depasquale Michael W was granted 139 shares, increasing direct ownership by 0.26% to 53,658 units (SEC Form 4)

Chief Legal Officer Sullivan James David was granted 139 shares, increasing direct ownership by 0.31% to 44,851 units (SEC Form 4)

Chief Technology Officer Lacous Mira K was granted 139 shares, increasing direct ownership by 1% to 10,758 units (SEC Form 4)

BIO-key International Inc. Leadership Updates

BIO-key Showcases Next-Generation Identity & Biometric Authentication Solutions at Premier Tech and Cybersecurity Events: GITEX 2025 in Dubai and 19ENISE in Spain

BIO-key Partners with Ping Identity to Bring its Cutting-Edge Biometric Authentication to Ping Customers

Identity and Access Management Software Provider BIO-key Names Seasoned Financial Services Executive Cameron E. Williams to its Board of Directors

Identity and Access Management Solutions Provider BIO-key Adds Proven Security Sales Leaders in Planned Senior Management Transition

BIO-key International Inc. Financials

Digital Identity and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 14th at 10am ET

BIO-key, Provider of Identity and Access Management Solutions with Enhanced Biometrics, Hosts Q2 Investor Call Wed. Aug. 13th at 10am ET

BIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET

BIO-key, Provider of Identity and Access Management Solutions Enhanced with Biometric Authentication Hosts Q1 Investor Call Fri. May 16th at 10am ET

BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET

Identity, Access Management & Biometric Solutions Provider BIO-key International Hosts Q4 Investor Call Thursday, March 27th at 10am ET

BIO-key Reports Q3'24 Revenue Rose 18% to $2.1M, Reduced Q3'24 Net Loss, and Improved Cash Position; Hosts Investor Call Tomorrow, Fri. Nov. 15th, 10am ET

Identity and Access Management and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 15th at 10am ET

BIO-key Reports Reduced Net Loss and Cash Used in Operations on Lower Q2'24 Revenues; Hosts Investor Call Thu. Aug. 15th at 10am ET

Identity and Access Management Solutions Provider BIO-key Hosts Q2 Investor Call Thursday, August 15th at 10am ET

BIO-key International Inc. Large Ownership Changes

Amendment: SEC Form SC 13G/A filed by BIO-key International Inc.

SEC Form SC 13G filed by BIO-key International Inc.

SEC Form SC 13G/A filed by BIO-key International Inc. (Amendment)

SEC Form SC 13G/A filed by BIO-key International Inc. (Amendment)

SEC Form SC 13G filed by BIO-key International Inc.

SEC Form SC 13G/A filed by BIO-key International Inc. (Amendment)

SEC Form SC 13G/A filed